Total planned funding: $283,426,816
Allocations
Countries/Regions
| Eswatini | $283,426,816 |
Organizational Types
| Private Contractor | $72,845,608 |
| University | $58,683,489 |
| Unknown | $49,066,443 |
| NGO | $44,879,277 |
| Own Agency | $36,823,967 |
| Host Country Government Agency | $8,872,150 |
| FBO | $5,360,534 |
| Multi-lateral Agency | $4,585,650 |
| Other USG Agency | $1,523,267 |
| Implementing Agency | $786,431 |
Program Areas
| Treatment | $85,772,846 |
| Care | $76,346,350 |
| Prevention | $53,048,151 |
| Governance and Systems | $31,327,101 |
| Management and Operations | $23,231,896 |
| Testing | $13,700,472 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $67,350,419 |
| HKID: Care: Orphans and Vulnerable Children | $29,600,442 |
| HBHC: Care: Adult Care and Support | $26,762,704 |
| HVMS: Management and Operations | $23,231,896 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $20,134,180 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,034,067 |
| HVCT: Testing: HIV Testing and Counseling | $13,700,472 |
| OHSS: Health Systems Strengthening | $13,319,161 |
| HVTB: Care: TB/HIV | $12,827,288 |
| HVSI: Strategic Information | $12,365,851 |
| HTXD: Treatment: ARV Drugs | $10,176,014 |
| PDTX: Treatment: Pediatric Treatment | $8,246,413 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,540,014 |
| PDCS: Care: Pediatric Care and Support | $7,155,916 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,279,890 |
| HLAB: Laboratory Infrastructure | $5,642,089 |
| HMBL: Biomedical Prevention: Blood Safety | $2,060,000 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Columbia University:
$51,931,950
Countries/Regions
Not Available:
$35,155,563
Countries/Regions
Pact, Inc.:
$33,263,890
Countries/Regions
USG Aggregated Agencies:
$21,097,252
Countries/Regions